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Summary
Fl rats primed with normal parental strain lymphocyte populations and restimulated in culture
with parental lymphoblasts generate potent cytotoxic T cell responses to unusual antigen systems.
Here we describe in the Lewis (L)/DA anti-DA combination an antigen system most likely of
mitochondrial origin with the following properties: it is transmitted maternally from DA strain
females, inherited in an extra-chromosomal manner, restricted by class I RTIA° major histocom-
patibility complex gene products, extinguished on target cells treated with chloramphenicol,
and its pattern of expression in different rat strains correlates with restriction fragment-length
polymorphisms of mitochondrial DNA. Sequence analysis of the rat NDI gene indicates that
the maternally transferred factor in the rat is not a homologue of the maternally transmitted
factor responsible for the mitochondrial antigen in mice. In keeping with its inheritance from
DA females, this antigen is present on target cells from (DA female x L male)F1 donors and
all other Fl combinations derived from DA female parents, but absent from target cells from
some Fl combinations (L/DA and Wistar-Furth [WF]/DA) derived from DA strain males. The
presence of this antigen in other Ft combinations (Brown Norway [BN]/DA, August 2880
[AUG]/DA, and PVG/DA) indicates that this mitochondrial antigen system is shared by the
DA, BN, and PVG strains, but not by the L and WF strains.
A a general rule, Fl animals derived from matings be-
tween inbred strains do not react to cells or tissue grafts
of parental origin. Usually, parental strain alloantigens are
expressed codominantly in F1 offspring; thus, for reasons of
self tolerance, these antigens fail to provoke responses in F1
hosts. Interesting exceptions to this rule are responses to the
sex-linked antigen (HY) ofmice and rats (1, 2), the hemato-
poietic histocompatibility antigen (Hh)t of mice (3, 4), the
maternally transmitted antigen (Mta) of mice (5), idiotypic
markers of parental TCRs in both species (6, 7), as well as
certain other antigen systems not yet well defined (8, 9).
Analysis of some of these examples of Fl antiparental re-
activity indicates that CTL are involved in the response (10)
and that the target antigen is clearly lacking in the Fi re-
sponder. For example, expression of Mta depends on Hmt,
1 Abbreviations used in this paper. AUG, August 2880; BN, Brown Norway;
CAP, chloramphenicol; Hh, hematopoietic histocompatibility; L, Lewis;
WF, Wistar-Furth.
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an MHC-linked class I-like gene (5, 11, 12), 02 microglob-
ulin (11), and maternally transmitted factor (Mtf), a mito-
chondrially-encoded peptide (13). Because mitochondrial DNA
is maternally inherited (14), certain Fl strain combinations
lacking this peptide are able to respond to its presence in pa-
rental cells. It should be noted that CTL recognition of the
murine Mta system differs in one important respect from that
of more conventional antigen systems; the lytic response to
the Mtf peptide is restricted by an MHC class I-like gene
product rather than the prototypic class I H-2K, D, and L
MHC molecules (10, 15).
During the course of experiments designed to produce cyto-
toxic T cells in Fl rats against idiotypic determinants of
alloreactive parental strain T cells, we noted in some strain
combinations that the responding Fl T cells showed lytic
specificity for target lymphoblasts of parental origin and also
for target cells from syngeneic Fl donors derived from recip-
rocal matings. At least two different antigen systems appear
to be involved. One (H), the subject of the next paper in
this series (see accompanying paperII [16]), is present on target
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the class I-like MHC region of the rat. The other (MTA),
the subject of this report, is most likely of mitochondrial
origin; it is transmitted maternally, inherited in an extra-
chromosomal manner, restricted by class IRT1A MHCgene
products, sensitive to treatment with chloramphenicol, and
its patternofexpression in differentratstrains correlates with
RFLP and sequence analyses of mitochondrial (mt) DNA.
Conditions forgenerating highly potent CTL specific forthese
atypical antigen systems require (a) in vivo priming of Ft re-
cipients with antigen-bearing parental T cells that include
subpopulations reactive to host alloantigens, a circumstance
that appears to bypass otherwiseineffective helper responses
to these antigens; and (b)in vitrorestimulationwith antigen-
bearing lymphoblasts (see accompanying paper III [17]).
Materials and Methods
Animals.
￿
Throughout this paper, the female parent of an in-
terstrain mating is designatedfirst. Therat strains used in this study,
along with their MHC haplotypes are indicated in Table 1.
Throughout thetext, we referto rat strains in terms ofalleles they
express in the various MHC regions. Thus, DA (RT1°°') =
A°BID-C'°'), or for brevity, aaavl. Rats of the DA strain were
purchased from Bantin andKingman (Freemont, CA); Lewis (L),
Wistar-Furth (WF), and Brown Norway (BN) rats were obtained
from Harlan SpragueDawley, Inc. (Indianapolis, IN);thePVGcon-
genicandrecombinant strainswere derived from theanimal colony
maintained at the Institute for Animal Physiology and Genetics
Research (Cambridge, UK); and rats of the August 2880 (AUG)
strain as well as allinterstrain Ft animals were bred and maintained
at our animal facilities in La Jolla.
Generation ofKiller Cells.
￿
To generate killer cells from Fl
responders, lymph node cells (1.5 x 10' in 0.1 ml) from DA rats
were injected into the hind foot pads of L/DA recipients; donors
and recipients were ofidentical sex. Cell suspensions were prepared
10 d later from the enlarged popliteal lymphnodes o£therecipients
and stimulated in culture with irradiated (3,000 rad) parental lymph
node cellspreviously activated for3d with ConA (3 Ag/ml). Cul-
tures consisted of 10' responder cells and 106 stimulator cells in
upright T25 flasks (Corning GlassWorks, Corning, NY)containing
10 ml of Tcell medium (RPMI 1640 with FCS [8%; J.R. Scientific,
Woodland, CA], Hepes [10 mM; Sigma Chemical Co., St. Louis,
MO], 2-ME [50,uM; Bio-RadLaboratories, Richmond, CA], In-
domethacin [1 1AM; Sigma Chemical Co.], and penicillin-strep-
tomycin [5 U/ml and 50 FAg/ml, respectively; M.A. Bioproducts,
Walkersville, MD]) supplemented with a-methyl mannoside (50
mM; SigmaChemical Co.). 5 dlater, cells from thesecultures were
used either in lyticassays or restimulated to provide killer cells for
repeat experiments. For restimulation, responder (2 x 106) and
stimulator (2 x 106) cellswere cultured for 4d as described above.
In all cases, stimulator cells were mitogen-activated blast cells;
normal lymph node cell populations proved to be totally ineffec-
tive (see accompanying paper III [17]).
MHC-specific killer cells were generated by culturinglymphnode
responder cells (2.5 x 10') for 6 d with irradiated (3,000 rad)
spleen stimulator cells (2.5 x 10') in upright T75 flasks con-
taining 25 ml T cell medium supplemented with a-methyl man-
noside (50 mM) and supernatant (10%) from Con A-stimulated
spleniccell cultures. To remove erythrocytes, cells from one spleen
were pelleted and resuspended for 5 min at room temperature in
a 5-ml mixture of TRIS base (20 mM; Sigma Chemical Co.) and
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Table 1.
￿
Rat Strains Used in This Study and Their RTI
MHC Haplotypes
ammonium chloride (0.15M) in distilledwateradjusted to pH 7.2.
The cells were then diluted in 15 ml T cell medium and washed
three times before culture.
Frozen Cell Storage.
￿
In some instances, Con A-activated cells
were frozen, stored at -70°C, andused as target cells afterthawing.
For freezing, 1 ml of freezing medium (FCS containing 10%
DMSO, 3% glucose, and 25% RPMI 1640) was added to pellets
of 1-10 x 106 cells; the medium was added ice cold and thecells
maintained at 4°C for60 min before storage in a styrofoam con-
tainer at -70°C. Cells were thawed slowly by adding l0'vol of
ice-cold T cell medium; they were then cultured overnight in media
supplemented with CASUP (10%) and cr-methyl mannoside (50
MM).
Lytic Assays. Target cells (1-3 x 106) were pelleted, then
resuspended in one drop of FCS and 100 uCi "Cr (0.1 ml), and
incubated at 37°Cwith gentle agitation for 1-2 h. Generally, 5-10
x 103 targets were used per well. Duplicate or triplicate three-
fold dilutions of killer cells were added starting at E/T ratios of
30:1 or 60:1. For cold target competition assays, effector/hot target
cell ratios were 30:1, and dilutions of cold, unlabeled target cells
were added in triplicate at cold/hot target cell ratios starting at
80:1. Percent specific lysiswas calculated from theequation: 100x
(experimental - spontaneous release)/(maximum uptake - spon-
taneous release). Generally, maximum uptake values were in the
range of 800-3,000 cpm, and spontaneous release values were
10-20%.
Reagents.
￿
Chloramphenicol (CAP) was added to target cells
in a concentration of 100Ag/ml for 24 h before labeling with "Cr.
MAC 30 is a rat monoclonal alloantibody of the IgG2c isotype
specific for RTIA'; it has been used in the past to block lysis by
killer cellsspecific for or restricted to this classI gene product(18) .
R3-40, a rat mAb standard of the same isotype (Pharmingen, San
Diego, CA) was used as control. Both of these antibodies were
used in fivefold dilutions starting at 12 Nag/ml.
RFLP Analysis ofmtDNA.
￿
Total cellular DNA was isolated
from spleen and kidney. 6-8 Ftg DNA was digested with restric-
Strain
DA
A
a
RTI region
BID
a
C
avl
L 1 I I
WF u u u
BN n n n
AUG c c c
PVG c c c
PVG-RTI,,' a a avl
PVG-RT1" u u u
PVG.R1 a x c c
PVG.R8 a x u u
PVG.R19 a a x c
PVG.R20 c c x avl
PVG.R23 u x a avltion enzymes, subjected to electrophoresis on 0.7% or 1% agarose
gels, and transferred to nylon membranes (19). Blots were hybrid-
ized with "P-labeled (20) mouse mtDNA (BamHI/PstI fragments
contained in pUC 18 plasmids; Yonekawa, H., E. Hermel, and K.
Fischer Lindahl, manuscript in preparation) and cohybridized with
an excess ofunlabeled pUC 18. Two post-hybridization washes were
performed in 2 x SSC for 5 min at room temperature, followed
by two washes in 40 mM sodium phosphate (pH 7.2), 0.1% SDS
for 20 min at 65°C.
Polymerase Chain Reaction (PCR).
￿
Amplification of the 5' end
of the NDI gene was conducted by PCR (21). Oligonucleotide
primers corresponded to sequences at the 16S rRNA/tRNAI-Eu
junction (AAACTGCAGCCCAAGTTATTAGGGTGG ; nt 2646-
2673, with the introduced PstI site highlighted) and within the
NDI gene (CCCGGATCCAGAGGGTTGGGGCGAT, nt 2944-
2960, with introduced BamHI site highlighted) (22). Amplifica-
tions were carried out in reaction volumes of 25 /Al containing 50
pM ofeach oligonucleotideprimer, reverse transcriptase buffer (23),
125 uM of each deoxynucleotide triphosphate, 5-10 ng rat total
cellular DNA, and 1 U Taq polymerise (Cetus Corp., Emeryville,
CA) under 50 ul mineral oil. The PCR reaction was carried out
for 30 cycles with denaturation and extension steps of 94°C for
1 min and 65°C for 3 min, respectively.
Sequence Analysis ofmtDNA.
￿
Reaction products were purified
by ethanol precipitation and digested with BamHI and Pstl. The
digested DNA was subjected to electrophoresis in 2% Nusieve/1%
GTG agarose (FMC), isolated from the gel, and cloned into pUC
18. Template DNA was amplified twice, and two positive clones
from each amplification were sequenced to identify and avoid mis-
incorporation artifacts. Double-stranded DNA was sequenced by
the dideoxy chain termination technique (24, 25). Both the coding
and noncoding DNA strands were sequenced.
Results
A Maternally Transmitted Antigen System Detected by CTL.
L/DA anti-DA CTL were tested for their lytic activity on
a panel of 5'Cr-labeled target cells from various strains and
their Fl hybrid combinations (Fig. 1, A and B) . Two find-
ings were unexpected: (a) targets from parental strain DA
donors were lysed, but those from other homozygous donors,
L, BN, AUG, and WF, were not; and (b) target cells from
hybrid progeny of DA females or males were also lysed, ex-
cept in two strain combinations, L/DA and WF/DA, where
target cells from hybrid progeny ofDA males were unaffected.
As controls, MHC-specific CTL (e.g., DA anti-L) were used
to demonstrate that target cells not lysed by L/DA anti-DA
CTL were susceptible to lysis by CTL of appropriate specificity
(data not shown).
Thus, DA/L and DA/WF animals, progeny ofDA mothers,
appear to express a maternally transmitted antigen system,
which we have provisionally termed MTA, that is lacking
in offspring of reciprocal Fl matings to DA males. The pres-
ence of this antigen in other Fl combinations, BN/DA and
AUG/DA, suggests the possibility that the maternally trans-
mitted component of this antigen in DA females may also
be transmitted by BN and AUG females, but not by L and
WF females. Evidence that the killer cells that detect this
antigen system are T cellsis provided by the finding that lysis
is blocked by R73, a mAb specific for the rat TCR-tx/ß (26)
(see accompanying paper 111 [17]).
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Figure 1.
￿
Lytic activity of L/DA anti-DA CTL against s1Cr-labeled
target cells ofvarious origin. Except thosefrom L/DAand WF/DAdonors,
all RTI-1 * target cells are lysed. Evidently, MTA expression on Fl target
cells depends upon a MTF inherited from DA strain females that is also
present in AUG and BN females, and absent in L and WF females.
The results shown in Fig. 2, A-C confirm this maternal
effect with cold target competition analysis; unlabeled L/DA,
WF/DA, BN, AUG, and L lymphoblasts fail to block lysis
of labeled DA/L target cells, while lymphoblasts from any
other Fl combinations involving DA matings blocked lysis.
Direct lysisand cold target competition were assayed in >100
different experiments. On some occasions, WF and WF/DA
target cells were lysed by L/DA anti-DA CTL well over back-
ground levels, but never to the extent that DA, DA/L, or
DA/WF target cellswere lysed (see example in Fig. 6). Also,
while WF and WF/DA cells sometimes showed some lysis,
they were never effective in cold target competition assays
with DA/L target cells (data not shown).
Requirements for the RT1°°' Haplotype: Backcross Studies.
Fig. 3 shows the results of three experiments designed to assess
the role of the RTI°' MHC haplotype in the maternally
controlled expression in DA/WF targets of the MTA antigen
detected by L/DA anti-DA CTL. A panel of 33 backcross
progeny of DA/WF x WF (avl /u x u/u) matings were
typed for expression of the segregating RTI°°' haplotype by:
(a) MLC responses to RTI°°' stimulators; (b) target cell lysis
by L anti-DA (1 anti-avl) MHC-specific CTL; and (c) flow
cytometric analysis with L anti-DA alloantisera or with MAC
30, a mAb specific for the class I RTIA° gene product of DA
rats (18). A total of 14 of these backcross donors were typed
to be RT1°°'+ by these three assays, and all of the 14 animals
were MTA+, their target cells being susceptible to lysis by
L/DA anti-DA CTL; no individual was found to be
RTI°°'+, MTA- , or RTI°°'- , MTA+ . We conclude from this
analysis that expression of MTA requires the RTI°°' haplo-
type. Such a lack of segregation of MTA and RTI°°' indi-
cates that MTA is either: (a) the product of a gene(s) en-
coded within MHC or closely linked to it, whose expression
is maternally controlled; or (b) that it is a maternally inherited,
extra-chromosomal product, perhaps ofmitochondrial origin,
recognized by CTL in the context of RTI'°' MHC gene
products.COLDMOT
MHC Restriction of MTA: Analysis of Intra-MHC Recom-
binants. Two elements seem to be required for expression
of MTA: (a) a maternally transferred factor derived from fe-
males of the DA, BN, AUG, and PVG (see below) strains,
but not from the L or WF strains; and (b) the presence of
the RTY°°' MHC haplotype. Previous efforts by one of our
groups (G.W Butcher, et al.) have generated a series of intra-
MHC recombinants involving the RTl"°l , RTI", and RT11
haplotypes on the PVG background; these recombinants define
the major class I (RTIA), class II (RTYB/D), and class I-like
(RT1C) regions of the rat MHC locus (27). To identify the
RT1 region required for MTA expression with these recom-
binant strains, it was first necessary to determine whether
PVG-RTY°vi rats express MTA. Several experiments indicated
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Figure 3.
￿
Expression of MTA requires the RTlavl haplotype. L/DA
anti-DA CTL were incubated with s1Cr-labeled target cells from DA/WF,
WF/DA, WF, BC.a* and BC.a - donors. BC.a* and BC.a - animals are
RT-" and Rn-t- backcross (BC) progeny of matings between
DA/WF female and WF male rats. The three different symbols (X, ",
and O) represent three different experiments. 33 different backcrossprogeny
were derived from four matings.
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All target cells susceptible
to lysis by L/DA anti-DA CTL effec-
tivelyblock lysis oflabeled DA/L target
cells in cold target competition assays.
that this is the case; cold target cells from DA and DA/L
donors, but not from L/DA donors, block lysis of labeled
PVG-RTl°vt target cells (data not shown).
This finding permitted us the next step of assessing the
expression of MTA on target cells of the PVG MHC con-
genic strains (ccc, aaavl, and uuu), as well as the intra-MHC
recombinant PVG strains (acc, aac, auu, ccavl, and uaavl ),
both by direct lysis using L/DA anti-DA CTL (Fig. 4 A)
and cold target competition assays with labeled DA/L target
cells (Fig. 4 B) . Thus, these experiments clearly demonstrate
a requirement for the a allele of the RTIA region for expres-
sion ofMTA; cells from donors expressing the ccavl or uaavl
haplotypes on the PVG background were not lysed, nor were
target cells from MTF negative WF/DA and L/DA donors,
which express the aaavl haplotype.
Further Evidencefor RTIA° Involvement in MTA Expression:
Inhibition ofLysis with a mAb Specific for RT1A°. MAC 30
is a rat mAb specific for the RT1A' molecules (18). Fig. 5 A
shows that its presence markedly inhibits lysis of DA/L target
cells by L/DA anti-DA CTL; as expected, it also inhibits
MHC-specific lysis of DA/L target cells by L/WF (Ill/uuu)
anti-DA (aaavl) CTL (Fig. 5 B) . This antibody fails to block
the lytic effects of MHC-specific DA/L (aaavl /Ill) CTL on
WF (uuu) target cells (Fig. 5 C), suggesting that its inhibi-
tory effects on anti-MTA lysis occur at the target cell level
and not by inhibiting the killer cell directly.
Extra-chromosomal Inheritance ofMTA.
￿
Studies described
above demonstrate that lack of segregation of MTA and
RTI--I in backcross offspring of DA/WF (RTla0 iu) x WF
(RT1u) matings. The results presented in Fig. 6 indicate the
basis for this lack of segregation; the maternally transmitted
component of the MTA target structure detected by L/DA
anti-DA CTL is inherited extra-chromosomally. Female
RT1u (RT1°°' - , MTA-) offspring of the backcross mating
described above and in Fig. 3, derived ultimately from a DA
female ancestor, were mated to WF/DA (RTlu%°', MTA - )
males. Of 13 progeny typed, six were RTI°°'+ and their
target cells were lysed by L/DA anti-DA CTL; target cells
from the remaining seven RTI
ulu progeny were not. There-
fore, a maternally transferred factor derived from a DA fe-
male ancestor, whose product is not recognizable in the con-
text of the backcross RTIu haplotype, is again detectable in
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cells from progeny of a subsequent testcross mating where
RTI°V' is introduced from an MTA- WF/DA male parent.
Chloramphenicol Sensitivity ofMTA. The precedent already
established in mice of a maternally inherited antigen system
determined by mtDNA (13), detectable with CTL (10), and
sensitive to treatment with CAP (28) raises the question
whether the present MTA system in rats might be similar.
To explore this possibility, DA/L target cells were treated
with CAP for 24 h before labeling with s'Cr. CAP is a
selective inhibitor of mitochondrial, but not of cytoplasmic,
translation (29). CAP treatment ofDA/L target cells inhibited
lysis by L/DA anti-DA CTL (Fig. 7 A), but, as expected,
CAP treatment did not inhibit lysis of DA/L target cellsby
DA anti-L CTL (Fig. 7 B) . Thus, the results of this experi-
ment support the extra-chromosomal inheritance of MTA
and suggest that this antigen is either ofmitochondrial origin
or that its expression depends on mitochondrial protein syn-
thesis.
Correlation ofMTA Expression with mtDNA Haplotppes.
￿
In
the mouse, Mta depends upon a mitochondrial gene locus
(Mtf) (13), and alleles ofMtfcorrelate with RFLPs (30, 31).
To determine whether this might be so for MTA of rats, we
examined mtDNA from four MTF+ rat strains (DA, BN,
AUG, and PVG), two MTF' strains (L, WF), and an
MTA+ DA/WF x WF backcross donor as a control. Fig.
A UDA anti-DA CTL
￿
B UWF anti-DA CTL
601 DAILTARGETS
￿
60 i DA'LTARGETS
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The presence of MTA on target cells requires
expression of the a allele of the class I RTIA MHC locus.
L/DA anti-DA CTL were (A) tested for lysis on s'Cr-labeled
target cells from various sources, including the MHC con-
genic and recombinant strains on a PVG background, or (B)
tested in cold target competition assays onlabeled DA/L target
cells with unlabeled target cells from these various sources.
8 shows that three RFLP haplotypes could be detected after
digestion of mtDNA with EcoRI, HhaI, and HincII. Diges-
tions with BamHI, Bc1I, HindIII, MspI, and PstI failed to
reveal any DNA polymorphisms.
The EcoRI digestions yielded the A and B patterns de-
scribed by others (32, 33) . The MTF+ strains DA, AUG,
and PVG displayed the A pattern, while the MTF - strains
L and WF fell into the B family. The MTA+ backcross con-
trol (DA/WF x WF) also expressed the A haplotype, as
would be expected from maternal inheritance ofmtDNA (14) .
A third mtDNA haplotype is revealed in the MTF+ BN
strain; it shares the EcoRI A, B, and C bands with DA and
the combined D+E band with MTF- L and WF strains.
Comparison of the HhaI digests shows that the MTF+
strains DA, AUG, PVG, and BN share one pattern, while
MTF` L and WF mtDN revealed a second pattern. In con-
trast, HincII digests of BN mtDNA gave a pattern similar
to that of L and WE It therefore seems clear that the
MTF - strains L and WF have a lineage of mtDNA distinct
from the MTF+ DA, AUG, and PVG strains, while BN
mtDNA shares features of both.
Sequence ofthe Rat Mitochondrial NDI Gene.
￿
Analysis of
rat-mouse somatic cell hybrids demonstrated that rat mito-
chondria produce a factor that crossreacts with the mouse
Mtf' peptide (Loveland, B. E., J. Rolf, Y Murata, H. Yone-
Figure 5.
￿
Further evidence of RTIAa involvement in
MTA expression. (A) MAC 30, a mAB specific for
RnA° gene products, blocks lysis of DA/L target cells
by anti-MTA CTL. For control purposes, this same anti-
body (B) blocks lysis of DA/L target cells (aaav11114 by
class I-specific L/WF anti-DA CTL, but (C) does not
inhibit lysis ofWF target cells (uuu) by DA/L CTL. This
latter finding indicates that the inhibitory effects ofMAC
30 are not exerted at the CTL level. A control mAb of
the same isotype, but different specificity (see Materials
and Methods) has no effect.60 -
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Figure 6.
￿
Expression of MTA involves a maternal component that is
inherited extra-chromosomally. L/DA anti-DA CTL were tested for lysis
on DA/WF, WF/DA, and WF target cells, and on target cells from test-
cross (TC) progeny ofRn-1 - DA/WF x WF females (BC.a - in Figs.
3) and WF/DA males. This testcross was designed to provide progeny
from matings of MTF+, MTA -, RTlav' - females and MTF-, MTA-,
RTl-1+ males to determine whether an extra-chromosomally inherited
component (MTF) in the female lineage, together with the paternally in-
herited RTI°°' haplotype, would lead to the re-expression of MTA. The
three different symbols (X, 0, and O) represent three different experi-
ments. The testcross animals were derived from three different parental pairs.
kawa, and K. Fischer Lindahl, manuscript in preparation) .
This factor is most likely the NH2 terminus of the rat ND1
protein, which is nearly identical to the mouse homologue
for the first 38 amino acids, including an isoleucine at the
critical position 6; the differences are Phe --> Tyr in position
2 and Val - Ile in position 11 (mouse - rat) (34). To deter-
mine whether the mitochondrial ligand detected by L/DA
anti-DA CTL is derived from the rat ND1 gene, we sequenced
the 5' end of this mitochondrial gene from L, DA, and BN
rats (Fig. 9). From nucleotide 2728 to 2961, including the
first 78 codons of the NDI gene, we found two silent base
changes, shared by L and BN but not by DA, but no amino
acid differences between the three strains. Therefore, we con-
clude that the rat MTF is not a homologue of the mouse
Mtf, and that it is encoded elsewhere in the mitochondrial
genome.
Discussion
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Previous studies by one of our groups have defined a
mitochondrially inherited antigen system in mice, peptides
of which are recognized by CTL restricted to medial or class
I-like gene products of the H-2 complex (35). The particu-
larly interesting feature of this murine antigen system is that
gene products of the major class I loci (K, D, and L) are
not involved in the presentation and recognition of this an-
tigen. The present studies describe for the first time in rats
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an antigen system that is also extra-chromosomally inherited
and maternally transmitted, but unlike the mouse, recogni-
tion of this antigen by CTL is restricted to classical class I
MHC gene products of the RT1A region.
This antigen system was first found by "priming" L/DA
F1 rats in vivo with parental strain DA lymphocytes under
conditions of a local GVH reaction and then restimulating
these Ft lymphocytes in culture with irradiatedlymphoblasts
of the same parental strain. These primed and restimulated
L/DA anti-DA cells were shown to lyse RTI°°1+ target cells
from homozygous donors (DA and PVG.RTI°°'; Fig. 1, A
and B, and 4 A) as well as RT1'°'+ target cells from Ft
progeny of some strain combinations (DA/BN, DA/AUG,
BN/DA, and AUG/DA) regardless of whether the RT1-'
haplotype was derived from the male or female parent. For
other RTI°°'+ Fl target cells (DA/L and DA/WF), however,
lysis occurred only ifDA females were used in the interstrain
mating; target cells from RTlav' - strains (L, BN, AUG,
WF, and PVG) and from certain RT1°°'+ Fl donors, where
DA was the male parent (L/DA, and WF/DA), were not
lysed (Fig. 1, A and B, and 4 A). These results were confirmed
in all instances by cold target competition assays; target cells
not susceptible to lysis by L/DA anti-DA CTL failed to block
lysis of labeled DA/L target cells (Fig. 2, A-C, and 4 B) .
The simplest interpretation of these findings is that this an-
tigen system depends upon a maternally transferred factor
shared in the DA, BN, AUG, and PVGstrains, and is different
or is absent in L and WF. It is interesting to note that there
is evidence from grafting experiments for a maternally trans-
mitted histocompatibility antigen difference between L and
BN (V Kren, personal communication). Expression of this
antigen system depends upon the RT1°°' haplotype (Fig. 3),
in particular, the class I RTIAa gene product (Fig. 4, A and
B); confirmation of this is provided by the finding that an
anti-RTlA' mAb effectively blocks lysis of target cells (Fig.
5 A).
Several lines of evidence support the conclusion that this
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￿
The expression ofMTA depends upon mitochondrial transla-
tion. DA/L target cells were incubated with or without 100,ug/ml chlor-
amphenicol (CAP) for 24 h before labeling with S1Cr, and then exposed
to (A) L/DA anti-DA CTL and (B) MHC-specific DA anti-L CTL.
Detected by Killer Cellsantigen system is either of mitochondrial origin or that it
depends on a particular allele of a polymorphic locus of
mtDNA . It is extra-chromosomally inherited (Fig. 6) ; it is
extinguished on target cells after treatment with chloram-
phenicol, an inhibitor ofmtRNA translation (Fig. 7) ; and
its expression correlates with RFLPs of mtDNA (Fig. 8) .
The murine Mtf is derived from the NH2 terminus of the
mitochondrial gene ND1 (13) . However, the rat MTF ap-
pears not to be a homologue of the murine Mtf, sequence
lysis of the rat mitochondrialND1 gene revealed no predicted
amino acid differences among the MTF+ DA and BN rat
strains and the MTF - L strain (Fig. 9) .
There are several ways to find the rat MTF. From the re-
striction maps of rat mtDNA (36, 37), it is possible to locate
the polymorphic restriction sites that we detected in L, DA,
and BN mtDNA. Both L and WF have lost an EcoRl site
from the junction of the ribosomal RNA genes, and they
-tRMA °
. . . .CAGAGCCAAGTAATTGCGTAAGACTTAAAACCTTGTTCCCAGAGGTTCAAATCCTCTCCCTAATA
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Figure 9 .
￿
Sequence of the PCR-amplified 5' end of BN, DA, and L
ratND1 . Nucleotide positionscorrespond with thepublished typeA Rattus
non,egicus sequence (22) . The asterisk marks the missingA nucleotide at
2779, while the additional C nucleotide at 2785-2786 is underlined . The
firstGTG codon, which has been proposed to act as a start codon in ro-
dents, is shown as encoding methionine (13, 58) . Nucleic acid differences,
causing silent changes in the BN and L strains, are indicated at positions
2825 and 2917 . These sequence data are available from EMBL/Gen-
Bank/DDBJ under accession number X56833 .
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Figure 8 .
￿
Southern blot analysis of
rat totalcellularDNA digestedwith the
indicated endonucleases andhybridized
with mouse mtDNA. Lane A, AUG;
laneB,BN ; laneD, DA ; lane L, Lewis;
lane P, PVG; lane 6, DA/WF x WF
backcross; lane W, WE EcoPLI bands
are indicated at the far left. Band E has
run off the gel .
have gained an HhaI site in the COI or Cyt b gene, while
L, WF, and BN have lost an EcoRI site in the ND1 gene,
as well as a HincII site in the noncodingD loop. In addition,
we have found that the 5' end of the NDI gene is shared
by L and BN .
This information is not sufficient to identify an area of
the mitochondrial genome likely to encode MTF. For this,
one may search for this gene using methods similar to those
used in thepast to find the mouse Mt,fgene (13) ; by sequencing
-11 kb ofmtDNA that encodes protein from strains L and
BN, and comparing this with the published sequence for type
A mtDNA (typical of the DA strain) (22), positions where
DA and BN are identical and differ from L can be identified .
Peptides having the sequences surrounding each of these po-
sitions can then be synthesized and tested for their ability
to mimic theDA MTF antigenwhen added to L/DA target
cells .
An alternative approach used in the past by Rammensee
and colleagues (38, 39) could also be considered ; this would
involve isolating mitochondrially encoded proteins ofDA rats
(first in the form of complex I, cytochrome b, cytochrome
oxidase, and Fl-ATPase), and assaying peptide digests for their
ability to mimic MTF. Once a single active protein was
identified, the candidate gene could be sequenced and syn-
thetic peptides tested as above .
The mouse Mtf peptide has a unique association with the
restriction element, Hmt . To date, we have found no evi-
dence that Mtf can be presented by the major class I restric-
tion elements of the mouse H-2 locus; similarlyHmt has not
been shown to present any other peptide antigen to T cells
(35, 40) . Because of this unique association, it has been sug-
gested the Hmt class I-like molecule might have special prop-
erties not found with the prototypical class I restriction ele-
ments, properties that would allow it to interact preferentially
with peptide ligands of mitochondrial origin, perhaps as part
of an intracellular transport mechanism (41) . However, the
current studies with the rat MTA system showing that class
I RTIA molecules can also present mitochondrial peptide
ligands argue against this notion .An alternative possibility for the association between class
I-like gene products and mitochondrial peptides seems worth
considering. Since the murine Mtf is an N142-terminal pep-
tide of a mitochondrially synthesized protein, it carries an
N-formyl-methionine (13). Unlike peptide presentation to
T cells by prototypical MHC molecules, this formyl group
on the N142-terminal residue is essential for Hmt binding,
whereas the methionine can be exchanged for phenylalanine
or valine (42). This raises the possibility that Hunt might
have a special pocket for binding peptides having an N142-
terminal formyl group, thus making this restriction element
specific for peptides of prokaryotic or mitochondrial origin
(43). It remains to be determined whether the rat mitochon-
drial peptide MTF is also a formylated N142-terminal peptide.
The finding here that a rat mitochondrial peptide can be
presented by a major classI MHC molecule supports the con-
clusion that any peptide may act as a minor histocompati-
bility antigen, irrespective of the cellular location or func-
tion ofthe protein from which it is derived (13) . If immune
surveillance has an important function in eliminating cells
presenting mutant forms of endogenous proteins (44), the
surface presentation ofmitochondrial peptides would be func-
tionally useful. The germline mutation state of mtDNA is
-10-fold higher than that ofnuclear DNA (45), and mtDNA
is a prime target for numerous chemical mutagens, such as
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